A 12-month lifestyle intervention does not improve cardiac autonomic function in patients with chronic kidney disease

Nina Huppertz1, Kassia S Beetham2, Erin J Howden3

  • 1School of Human Movement and Nutrition Sciences, University of Queensland, Brisbane, Queensland, Australia; Cardiology Department, Sandwell and West Birmingham Hospitals NHS Trust, Birmingham, United Kingdom.

Insights

A 12-month lifestyle intervention improved cardiorespiratory fitness in chronic kidney disease (CKD) patients but did not enhance cardiac autonomic function. A non-linear heart rate variability measure (α1) showed association with cardiorespiratory fitness changes.

Area of Science:

  • Cardiology
  • Nephrology
  • Exercise Physiology

Background:

  • Patients with chronic kidney disease (CKD) face elevated risks of autonomic dysfunction and cardiovascular disease.
  • Cardiac autonomic function is crucial for cardiovascular health and is often impaired in CKD.

Purpose of the Study:

  • To evaluate the impact of a 12-month lifestyle intervention (LI) with aerobic exercise on cardiac autonomic function in patients with stage 3-4 CKD.
  • To assess changes in cardiorespiratory fitness and heart rate variability (HRV) following the intervention.

Main Methods:

  • A pooled exploratory analysis of 113 patients with stage 3-4 CKD.
  • Participants engaged in a 12-month LI program (8-week gym-based, 10-month home-based exercise) or standard care (control group).
  • Assessed cardiorespiratory fitness (VO2peak), HRV measures, heart rate recovery, and chronotropic competence before and after the study.

Main Results:

  • The LI group demonstrated a significant increase in VO2peak (1.8 ml/kg/min) compared to the control group (-1.0 ml/kg/min).
  • No significant improvements were observed in HRV measures, heart rate recovery, or chronotropic competence in the LI group.
  • Changes in VO2peak were significantly associated with changes in a non-linear HRV measure (α1), independent of age and eGFR.

Conclusions:

  • A 12-month lifestyle intervention significantly improved cardiorespiratory fitness in CKD patients but did not alter cardiac autonomic function.
  • The non-linear HRV measure α1 may serve as a sensitive indicator for assessing cardiorespiratory fitness changes in CKD patients.
  • Further research is needed to explore exercise training modalities that effectively enhance cardiac autonomic function in this population.
Abstract

Related Concept Videos

Chronic Kidney Disease IV: Nursing Management01:18

Chronic Kidney Disease IV: Nursing Management

Nursing management is essential for preventing complications, maintaining stability, and improving patients' quality of life in chronic kidney disease (CKD). By using a structured approach, nurses help slow CKD progression and support effective patient care​.1. Comprehensive patient assessmentEffective management begins with nurses reviewing the patient’s medical history, and identifying key risk factors like diabetes, hypertension, and nephrotoxic drug use. Nurses assess signs of...
243
Chronic Kidney Disease III: Interprofessional Care01:28

Chronic Kidney Disease III: Interprofessional Care

Chronic kidney disease (CKD) requires collaborative and comprehensive management. CKD progresses through stages and can lead to end-stage kidney disease (ESKD) if untreated. Interprofessional collaboration and patient education are crucial, enabling patients to manage their health and improve their quality of life.Diagnostic approach for chronic kidney diseaseThe diagnosis of CKD primarily focuses on the glomerular filtration rate (GFR), which assesses kidney function by measuring how well...
281
Chronic Kidney Disease I: Introduction01:25

Chronic Kidney Disease I: Introduction

Chronic Kidney Disease (CKD) arises when the kidneys progressively lose their ability to function, ultimately leading to end-stage renal disease. At this advanced stage, the kidneys can no longer filter waste or maintain essential body functions, requiring renal replacement therapy (RRT) through dialysis or a kidney transplant for survival.Early-stage chronic kidney disease and detection challengesIn CKD's early stages, symptoms often remain absent because healthy nephrons compensate for...
490
Chronic Kidney Disease II: Clinical Manifestations01:24

Chronic Kidney Disease II: Clinical Manifestations

Chronic Kidney Disease (CKD) progressively impairs multiple body systems due to the accumulation of uremic toxins, which disrupt cellular functions across various organs.Neurologic symptomsNeurologic symptoms often arise early in CKD, as uremic toxin buildup drives changes in cognitive and motor functions. Patients frequently experience fatigue, headache, confusion, difficulty concentrating, and, in severe cases, seizures. Peripheral neuropathy commonly manifests as burning sensations in the...
481
Acute Kidney Injury III: Clinical Manifestations01:29

Acute Kidney Injury III: Clinical Manifestations

Acute Kidney Injury (AKI) progresses through distinct clinical phases: the oliguric, diuretic, and recovery phases, each marked by unique manifestations and challenges.Oliguric Phase:The oliguric phase is the initial stage of AKI, typically lasting 10 to 14 days. This phase is marked by a significant reduction in urine output, usually less than 400 mL per day, indicating decreased kidney function. Fluid retention is a prominent feature, leading to symptoms such as edema, hypertension, and...
694
Acute Kidney Injury VI: Nursing Management01:22

Acute Kidney Injury VI: Nursing Management

Acute Kidney Injury (AKI) results in an inability to maintain fluid, electrolyte, and acid-base balance. Effective nursing management is critical in improving patient outcomes and includes comprehensive patient assessment and targeted interventions.Comprehensive Patient AssessmentA detailed history collection is essential, focusing on any recent infections, nephrotoxic medication use, or chronic conditions such as hypertension and diabetes that may contribute to AKI. During the physical...
304